Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-08-27
1991-05-07
Siegel, Alan
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549 72, A61K 3138, C07D33322
Patent
active
050137514
ABSTRACT:
Disclosed are esters and amides of (+) suprofen, substantially free of the corresponding enantiomorp, (-) suprofen, having enhanced delivery characteristics on topical administration to the eye; also disclosed are pharmaceutical compositions comprising such (+) suprofen derivatives and methods of using them when indicated to achieve an anti-inflammatory effect on topical delivery to the eye.
REFERENCES:
patent: 4159986 (1979-07-01), Clemence
patent: 4559343 (1985-12-01), Han et al.
Van Daele, P. G. H. et al., Arzneim-Forsch (Drug-Res.), 25(10):1495 (1975).
Gerson Steven H.
Han Wesley W.
Alcon Laboratories Inc.
Arno James A.
Cheng Julie J. L.
Siegel Alan
Yeager Sally S.
LandOfFree
(+) Suprofen esters and amides as opthalmic anti-inflammatory ag does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (+) Suprofen esters and amides as opthalmic anti-inflammatory ag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (+) Suprofen esters and amides as opthalmic anti-inflammatory ag will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-939928